ALKS vs NSC · P/E 14, rev $1.56B vs P/E 18, rev $12.12B
Alkermes Plc (ALKS) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported NSC revenue for 2024-12-31 was $12.12B. Net income was $2.62B. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the ALKS and NSC stock pages for the full models.
Not investment advice.